COM:ROIVANT
Roivant Sciences Ltd.
- Stock
Last Close
11.82
22/11 21:00
Market Cap
8.31B
Beta: -
Volume Today
11.36M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
---|---|---|---|---|---|---|---|
net income | -749.37M - | -519.39M 30.69% | -900.23M 73.32% | -924.12M 2.65% | -1.12B 20.71% | 4.23B 479.32% | |
depreciation and amortization | 5.93M - | 18.86M 217.89% | 22.04M 16.86% | ||||
deferred income tax | -5.93M - | -4.36M 26.52% | |||||
stock based compensation | 58.86M - | 122.57M 108.24% | 84.96M 30.69% | 564.96M 564.98% | 217.78M 61.45% | 199.63M 8.34% | |
change in working capital | 49.67M - | 15.30M 69.21% | 71.94M 370.31% | 15.72M 78.15% | 6.34M 59.63% | 19.04M 200% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | 4.54M - | 6.60M 45.43% | 3.75M 43.13% | 15.40M 310.53% | 4.36M 71.70% | 22.68M 420.39% | |
other working capital | 45.14M - | 8.70M 80.73% | 68.19M 683.93% | 316K 99.54% | 1.99M 528.48% | -3.65M 283.74% | |
other non cash items | -383.40M - | -380.31M 0.81% | 191.20M 150.28% | -334.29M 274.84% | 33.45M 110.01% | 96.04M 187.14% | |
net cash provided by operating activities | -1.02B - | -761.83M 25.62% | -552.14M 27.52% | -677.73M 22.75% | -843.39M 24.44% | -765.27M 9.26% | |
investments in property plant and equipment | -11.40M - | -4.92M 56.86% | -5.81M 18.10% | -17.44M 200.31% | -12.69M 27.22% | -1.38M 89.11% | |
acquisitions net | -2.60M - | 1.77B 68,268.18% | -39K - | 107.86M 276,651.28% | -36.98M 134.29% | ||
purchases of investments | -43.61M - | -68.38M 56.78% | -28.25M 58.68% | 39K 100.14% | |||
sales maturities of investments | 46.21M - | 16.44M 64.42% | 320.17M - | 5.23B - | |||
other investing activites | -46.21M - | -20.05M 56.62% | 2.35M 111.74% | 561K 76.17% | -139.43M 24,954.55% | 5.24B 3,859.48% | |
net cash used for investing activites | -57.61M - | 1.69B 3,041.94% | -31.70M 101.87% | 303.30M 1,056.71% | -44.27M 114.60% | 5.20B 11,854.55% | |
debt repayment | -9.71M - | -32.06M 230.31% | -21.59M - | -30.14M 39.62% | -30.70M 1.86% | ||
common stock issued | 598.86M - | 1.35B 126.13% | 455.76M 66.35% | 313.42M 31.23% | 379.71M 21.15% | 438.56M 15.50% | |
common stock repurchased | -7.38M - | -1.19B 16,014.78% | -113K 99.99% | 316K - | 951K 200.95% | ||
dividends paid | -162.71M - | ||||||
other financing activites | 185.24M - | 83.48M 54.93% | 621K 99.26% | 14.96M 2,308.70% | 312.30M 1,987.81% | -43.76M 114.01% | |
net cash used provided by financing activities | 767.02M - | 217.16M 71.69% | 456.26M 110.10% | 306.79M 32.76% | 499.46M 62.80% | 419.36M 16.04% | |
effect of forex changes on cash | 1.43B - | 6.28M - | 616K 90.19% | ||||
net change in cash | 1.12B - | 1.34B 19.37% | -127.58M 109.55% | -67.64M 46.98% | -381.92M 464.62% | 4.86B 1,372.09% | |
cash at beginning of period | -269.58M - | 849.55M 415.14% | 2.27B 167.11% | 2.14B 5.62% | 2.07B 3.16% | 1.69B 18.41% | |
cash at end of period | 849.55M - | 2.19B 157.25% | 2.14B 2.00% | 2.07B 3.16% | 1.69B 18.41% | 6.55B 287.12% | |
operating cash flow | -1.02B - | -761.83M 25.62% | -552.14M 27.52% | -677.73M 22.75% | -843.39M 24.44% | -765.27M 9.26% | |
capital expenditure | -11.40M - | -4.92M 56.86% | -5.81M 18.10% | -17.44M 200.31% | -12.69M 27.22% | -1.38M 89.11% | |
free cash flow | -1.04B - | -766.75M 25.96% | -557.94M 27.23% | -695.16M 24.59% | -856.08M 23.15% | -766.65M 10.45% |
All numbers in (except ratios and percentages)